‘Free’ Screening? Know Your Rights to Get No-Cost Care
Some screenings and preventative tests are free under the Affordable Care Act. But this popular provision comes with challenges and ...
Tag: Pharmaceuticals
Medicare Surprise: Drug Plan Prices Touted During Open Enrollment Can Rise Within a Month
As early as three weeks after Medicare’s drug plan enrollment period ends on Dec. 7, insurance plans can change what ...
Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might think everyone living with Alzheimer’s wants unfettered ...
Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
The drug industry, patient advocates, and congressional Republicans have all attacked the FDA's decision to decline routine Medicare coverage for ...
Clinics Say State’s New Medicaid Drug Program Will Force Them to Cut Services
California’s sweeping new program to buy prescription drugs for its nearly 14 million Medicaid patients has alarmed health clinics that ...
Seeking Refills: Aging Pharmacists Leave Drugstores Vacant in Rural America
Attracting new pharmacists to independent drugstores, especially to rural settings, is difficult. More communities may lose their only drugstore.
Nursing Home Residents Overlooked in Scramble for Covid Antibody Treatments
Across the country, medical directors of skilled nursing and long-term care sites say they’ve been scrambling to obtain doses of ...
The Public Backs Medicare Rx Price Negotiation Even After Hearing Both Sides’ Views
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of ...
Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment — ...
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
The Food and Drug Administration’s approval in June of a drug purporting to slow the progression of Alzheimer’s disease was ...